Tools
Tools
Landberg, Rikard, Manach, Claudine, Kerckhof, Frederiek-Maarten, Minihane, Anne-Marie 
ORCID: https://orcid.org/0000-0001-9042-4226, Saleh, Rasha Noureldin M, De Roos, Baukje, Tomas-Barberan, Francisco, Morand, Christine and Van de Wiele, Tom
(2019)
Future prospects for dissecting inter-individual variability in the absorption, distribution and elimination of plant bioactives of relevance for cardiometabolic endpoints.
European Journal of Nutrition, 58 (2).
pp. 21-36.
ISSN 1436-6207
Preview |
PDF (Published_Manuscript)
- Published Version
Available under License Creative Commons Attribution. Download (2MB) | Preview |
Abstract
PURPOSE: The health-promoting potential of food-derived plant bioactive compounds is evident but not always consistent across studies. Large inter-individual variability may originate from differences in digestion, absorption, distribution, metabolism and excretion (ADME). ADME can be modulated by age, sex, dietary habits, microbiome composition, genetic variation, drug exposure and many other factors. Within the recent COST Action POSITIVe, large-scale literature surveys were undertaken to identify the reasons and extent of inter-individual variability in ADME of selected plant bioactive compounds of importance to cardiometabolic health. The aim of the present review is to summarize the findings and suggest a framework for future studies designed to investigate the etiology of inter-individual variability in plant bioactive ADME and bioefficacy. RESULTS: Few studies have reported individual data on the ADME of bioactive compounds and on determinants such as age, diet, lifestyle, health status and medication, thereby limiting a mechanistic understanding of the main drivers of variation in ADME processes observed across individuals. Metabolomics represent crucial techniques to decipher inter-individual variability and to stratify individuals according to metabotypes reflecting the intrinsic capacity to absorb and metabolize bioactive compounds. CONCLUSION: A methodological framework was developed to decipher how the contribution from genetic variants or microbiome variants to ADME of bioactive compounds can be predicted. Future study design should include (1) a larger number of study participants, (2) individual and full profiling of all possible determinants of internal exposure, (3) the presentation of individual ADME data and (4) incorporation of omics platforms, such as genomics, microbiomics and metabolomics in ADME and efficacy studies.
| Item Type: | Article |
|---|---|
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health |
| Depositing User: | LivePure Connector |
| Date Deposited: | 01 Nov 2019 14:30 |
| Last Modified: | 19 Oct 2023 02:34 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/72850 |
| DOI: | 10.1007/s00394-019-02095-1 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |